Galectin Therapeutics shares owned by Sovran Advisors
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Sovran Advisors
from 13F filings
Historical chart of Sovran Advisors investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Sovran Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Galectin Therapeutics by Sovran Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $214k | 186k | 1.15 |